IDEXX LABORATORIES INC /DE Equity Securities, FV-NI, Unrealized Gain (Loss)
IDEXX LABORATORIES INC /DE (IDXX) reported Equity Securities, FV-NI, Unrealized Gain (Loss) of $1.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss · last filed 2026-08-04
- IDEXX LABORATORIES INC /DE equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2026-06-30 was $1.23M.
- IDEXX LABORATORIES INC /DE equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2025-06-30 was $0.00.
| Period end | Equity Securities, FV-NI, Unrealized Gain (Loss) 3 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 6 month |
|---|---|---|
| 2026-06-30 | $1.23M 10-Q · filed 2026-08-04 | $1.23M 10-Q · filed 2026-08-04 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |